AI-generated summary
The authors randomized patients with nonsegmental vitiligo so that one lesion received the 308-nm excimer laser and a matching lesion received the 308-nm excimer lamp, over 24 twice-weekly sessions. They report similar efficacy for at least 50% repigmentation, with the lamp inducing more erythema at the same fluence. The study was monocentric and the abstract reports only 17 of 20 enrolled patients completing it.
- Who or what was studied
- Patients with nonsegmental vitiligo; 20 enrolled, 17 completed the study, 104 lesions treated
- Wavelengths
- 308 nm
- Limits stated in the abstract
- The study was monocentric and small, with 3 of 20 patients not completing the study.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on academic.oup.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Ultraviolet, Fluence, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.